SACCHARIN

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
182.0 -0.5 0 3 70.0 0 0.0
CAS
81072
UNII
FST467XS7D
SYNONYMS
ZINC ID(s)
Availability
Present in 80 ZINC catalogs

Known Active Genes

This compound has been observed to have activity at 10μM or less against the following gene(s).
Name Description Classification
A6YCJ1_9METZ Astrosclerin-3 Unclassified / Unclassified
CA Carbonic anhydrase Unclassified / Unclassified
NCE103 Carbonic anhydrase Enzyme / Enzyme-Other
MTCA2 Carbonic anhydrase 2 Enzyme / Enzyme-Other
CA7 Carbonic anhydrase 7 Enzyme / Enzyme-Other
CA4 Carbonic anhydrase 4 Enzyme / Enzyme-Other
MTCA1 Beta-carbonic anhydrase 1 Enzyme / Enzyme-Other
CA2 Carbonic anhydrase 2 Enzyme / Enzyme-Other
CA12 Carbonic anhydrase 12 Enzyme / Lyase
CA6 Carbonic anhydrase 6 Enzyme / Lyase
CA14 Carbonic anhydrase 14 Enzyme / Lyase
CA9 Carbonic anhydrase 9 Enzyme / Lyase
CA1 Carbonic anhydrase 1 Enzyme / Lyase
CA5B Carbonic anhydrase 5B, mitochondrial Enzyme / Lyase

Clinical Trials

This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
Code Date Title Phase Status
NCT02318446 2015-03-01 Efficacy Study of Folic Acid Supplementation in Adolescent Epileptics Phase 3 Not Yet Recruiting

(Browse) Purchasable Analogs in ZINC

Functions of Saccharin

Nns - Non-nutritive sweetener

Dosages

Route Formulation Per Unit Dose
Inhalation Aerosol, Metered 0.11%
Inhalation Aerosol, Spray 0.05%
Inhalation Solution
Oral Aerosol, Metered
Oral Granule, For Suspension 16MG
Oral Powder, For Solution
Oral Solution 1%
Oral Solution, Elixir
Oral Suspension 0.25%
Oral Syrup 0.07%
Oral Tablet 1.6MG
Oral Tablet (immed./comp. Release), Uncoated, Chewable
Oral Tablet, Extended Release 8MG
Sublingual Tablet 0.2MG
Topical Ointment 0.5%
Topical Solution

More Information

Usage Over Time

Comments